NR1H2
Oxysterols receptor LXR-beta
Also known as: LXR-b, LXRb, NER, NER-I, NR1H2_HUMAN, RIP15, UNR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55055
- Gene
- NR1H2
- Ensembl
- ENSG00000131408
- Chromosome
- 19
- Canonical length
- 460 aa
- Protein class
- Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
The liver X receptors, LXRA (NR1H3; MIM 602423) and LXRB, form a subfamily of the nuclear receptor superfamily and are key regulators of macrophage function, controlling transcriptional programs involved in lipid homeostasis and inflammation. The inducible LXRA is highly expressed in liver, adrenal gland, intestine, adipose tissue, macrophages, lung, and kidney, whereas LXRB is ubiquitously expressed. Ligand-activated LXRs form obligate heterodimers with retinoid X receptors (RXRs; see MIM 180245) and regulate expression of target genes containing LXR response elements (summary by Korf et al., 2009 [PubMed 19436111]).[supplied by OMIM, Jan 2010]
Canonical amino-acid sequenceUniProt
460 residues, UniProt reviewed canonical sequence.
>P55055|NR1H2
1 MSSPTTSSLD TPLPGNGPPQ PGAPSSSPTV KEEGPEPWPG GPDPDVPGTD EASSACSTDW
61 VIPDPEEEPE RKRKKGPAPK MLGHELCRVC GDKASGFHYN VLSCEGCKGF FRRSVVRGGA
121 RRYACRGGGT CQMDAFMRRK CQQCRLRKCK EAGMREQCVL SEEQIRKKKI RKQQQESQSQ
181 SQSPVGPQGS SSSASGPGAS PGGSEAGSQG SGEGEGVQLT AAQELMIQQL VAAQLQCNKR
241 SFSDQPKVTP WPLGADPQSR DARQQRFAHF TELAIISVQE IVDFAKQVPG FLQLGREDQI
301 ALLKASTIEI MLLETARRYN HETECITFLK DFTYSKDDFH RAGLQVEFIN PIFEFSRAMR
361 RLGLDDAEYA LLIAINIFSA DRPNVQEPGR VEALQQPYVE ALLSYTRIKR PQDQLRFPRM
421 LMKLVSLRTL SSVHSEQVFA LRLQDKKLPP LLSEIWDVHELocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR1H2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 141 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 141 nTPM
- bone marrow: 135 nTPM
- blood vessel: 124 nTPM
- heart muscle: 91 nTPM
- colon: 83 nTPM
- urinary bladder: 83 nTPM
Single-cell type
- syncytiotrophoblasts: 191 nCPM
- esophageal apical cells: 136 nCPM
- platelets: 109 nCPM
- megakaryocytes: 105 nCPM
- endometrial ciliated cells: 97 nCPM
- enterocytes: 95 nCPM
Immune cell
- eosinophil: 233 nTPM
- neutrophil: 196 nTPM
- basophil: 160 nTPM
- non-classical monocyte: 147 nTPM
- total PBMC: 129 nTPM
- intermediate monocyte: 126 nTPM
Brain region
- medulla oblongata: 90 nTPM
- thalamus: 76 nTPM
- pons: 74 nTPM
- midbrain: 74 nTPM
- cerebral cortex: 72 nTPM
- white matter: 71 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.38
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cholesterol homeostasis
- hormone-mediated signaling pathway
- intracellular receptor signaling pathway
- mRNA transcription by RNA polymerase II
- negative regulation of cholesterol storage
- negative regulation of cold-induced thermogenesis
- negative regulation of DNA-templated transcription
- negative regulation of gene expression
- negative regulation of inflammatory response
- negative regulation of lipid transport
- negative regulation of macrophage derived foam cell differentiation
- negative regulation of pinocytosis
- negative regulation of proteolysis
- negative regulation of response to endoplasmic reticulum stress
- negative regulation of transcription by RNA polymerase II
- negative regulation of type II interferon-mediated signaling pathway
- phosphatidylcholine acyl-chain remodeling
- positive regulation of cholesterol efflux
- positive regulation of cholesterol transport
- positive regulation of DNA-templated transcription
- positive regulation of fatty acid biosynthetic process
- positive regulation of gene expression
- positive regulation of high-density lipoprotein particle assembly
- positive regulation of lipid storage
- positive regulation of miRNA transcription
- positive regulation of pancreatic juice secretion
- positive regulation of transcription by RNA polymerase II
- positive regulation of triglyceride biosynthetic process
- regulation of lipid storage
- response to nutrient levels
- retinoic acid receptor signaling pathway
- positive regulation of secretion of lysosomal enzymes
Molecular functions
- apolipoprotein A-I receptor binding
- ATPase binding
- chromatin DNA binding
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- nuclear receptor activity
- nuclear retinoid X receptor binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Zinc finger, NHR/GATA-type
- Liver X receptor
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR1 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR1H2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR1H2 as an antibody target. Whether an autoantibody or antibody against NR1H2 could matter depends on whether native NR1H2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR1H2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR1H2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...